Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 15 | 2025 | 2034 | 2.910 |
Why?
|
| Endovascular Procedures | 4 | 2024 | 562 | 1.250 |
Why?
|
| Brain | 6 | 2025 | 1487 | 1.230 |
Why?
|
| Gangliosidosis, GM1 | 2 | 2025 | 19 | 1.170 |
Why?
|
| Brain Ischemia | 2 | 2022 | 403 | 0.930 |
Why?
|
| Stroke | 2 | 2023 | 1135 | 0.880 |
Why?
|
| Disease Progression | 2 | 2025 | 1039 | 0.820 |
Why?
|
| ErbB Receptors | 2 | 2013 | 111 | 0.780 |
Why?
|
| Glioma | 2 | 2013 | 102 | 0.760 |
Why?
|
| Intestines | 1 | 2021 | 157 | 0.690 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 2062 | 0.670 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 71 | 0.630 |
Why?
|
| Collagen | 1 | 2019 | 121 | 0.610 |
Why?
|
| Intracranial Aneurysm | 1 | 2022 | 335 | 0.610 |
Why?
|
| Kyphosis | 1 | 2018 | 5 | 0.600 |
Why?
|
| Achondroplasia | 1 | 2018 | 2 | 0.600 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2018 | 4 | 0.600 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 79 | 0.590 |
Why?
|
| Spine | 1 | 2018 | 48 | 0.580 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 63 | 0.580 |
Why?
|
| Blood Vessels | 1 | 2017 | 61 | 0.570 |
Why?
|
| Hydrogels | 1 | 2018 | 106 | 0.550 |
Why?
|
| Animals | 17 | 2024 | 19610 | 0.530 |
Why?
|
| Contrast Media | 3 | 2015 | 408 | 0.530 |
Why?
|
| Biomimetics | 1 | 2014 | 28 | 0.460 |
Why?
|
| Liposomes | 1 | 2014 | 98 | 0.450 |
Why?
|
| Organometallic Compounds | 1 | 2014 | 64 | 0.440 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 73 | 0.440 |
Why?
|
| Molecular Imaging | 1 | 2013 | 47 | 0.430 |
Why?
|
| Coordination Complexes | 1 | 2012 | 8 | 0.410 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 213 | 0.410 |
Why?
|
| Manganese Compounds | 1 | 2012 | 7 | 0.400 |
Why?
|
| Peroxidase | 1 | 2012 | 69 | 0.400 |
Why?
|
| Chlorides | 1 | 2012 | 31 | 0.390 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 292 | 0.380 |
Why?
|
| Brain Neoplasms | 2 | 2013 | 306 | 0.380 |
Why?
|
| Tomography, Optical Coherence | 2 | 2024 | 199 | 0.370 |
Why?
|
| Tay-Sachs Disease | 2 | 2022 | 34 | 0.360 |
Why?
|
| Cerebral Angiography | 2 | 2022 | 278 | 0.360 |
Why?
|
| Dogs | 2 | 2022 | 316 | 0.330 |
Why?
|
| Humans | 20 | 2025 | 59320 | 0.300 |
Why?
|
| Genetic Therapy | 3 | 2024 | 734 | 0.290 |
Why?
|
| Cattle | 2 | 2019 | 306 | 0.260 |
Why?
|
| Respiration | 2 | 2017 | 87 | 0.250 |
Why?
|
| Solubility | 2 | 2018 | 173 | 0.250 |
Why?
|
| Atrophy | 1 | 2025 | 64 | 0.240 |
Why?
|
| Neurofibromin 1 | 1 | 2024 | 11 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2019 | 569 | 0.230 |
Why?
|
| Rats | 3 | 2013 | 1907 | 0.230 |
Why?
|
| Neurofibromatosis 1 | 1 | 2024 | 28 | 0.230 |
Why?
|
| Codon, Nonsense | 1 | 2024 | 51 | 0.230 |
Why?
|
| Cerebral Arteries | 1 | 2024 | 39 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2023 | 265 | 0.220 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 2 | 2017 | 191 | 0.220 |
Why?
|
| Mice, Inbred DBA | 2 | 2014 | 84 | 0.220 |
Why?
|
| Female | 9 | 2025 | 30806 | 0.220 |
Why?
|
| Male | 9 | 2025 | 27483 | 0.220 |
Why?
|
| Mice | 7 | 2024 | 10256 | 0.220 |
Why?
|
| Neuroimaging | 1 | 2024 | 130 | 0.220 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2023 | 14 | 0.210 |
Why?
|
| Carotid Artery, Internal | 1 | 2023 | 66 | 0.210 |
Why?
|
| Rats, Nude | 2 | 2013 | 25 | 0.210 |
Why?
|
| Treatment Outcome | 2 | 2023 | 5142 | 0.200 |
Why?
|
| Mutation | 3 | 2018 | 2427 | 0.200 |
Why?
|
| Infarction | 1 | 2022 | 20 | 0.200 |
Why?
|
| Radial Artery | 1 | 2022 | 41 | 0.200 |
Why?
|
| Rabbits | 1 | 2022 | 330 | 0.190 |
Why?
|
| Case-Control Studies | 1 | 2025 | 1061 | 0.190 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 1221 | 0.190 |
Why?
|
| Thrombectomy | 1 | 2023 | 205 | 0.190 |
Why?
|
| Demography | 1 | 2021 | 178 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 636 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 4 | 2024 | 3189 | 0.180 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 211 | 0.180 |
Why?
|
| Cell Line, Tumor | 3 | 2015 | 1370 | 0.180 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 166 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 77 | 0.170 |
Why?
|
| Oxygen | 1 | 2022 | 307 | 0.170 |
Why?
|
| Injections | 1 | 2020 | 79 | 0.170 |
Why?
|
| Infant | 1 | 2025 | 1527 | 0.170 |
Why?
|
| Thalamus | 1 | 2020 | 62 | 0.170 |
Why?
|
| Child, Preschool | 1 | 2025 | 1838 | 0.170 |
Why?
|
| Weight Loss | 1 | 2021 | 259 | 0.160 |
Why?
|
| Implants, Experimental | 1 | 2019 | 5 | 0.160 |
Why?
|
| Stents | 1 | 2022 | 436 | 0.160 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 141 | 0.160 |
Why?
|
| Movement | 2 | 2017 | 146 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2017 | 454 | 0.150 |
Why?
|
| Myelin Basic Protein | 1 | 2018 | 23 | 0.150 |
Why?
|
| X-Ray Microtomography | 1 | 2018 | 26 | 0.150 |
Why?
|
| Oligodendroglia | 1 | 2018 | 33 | 0.150 |
Why?
|
| Myelin Sheath | 1 | 2018 | 35 | 0.150 |
Why?
|
| Diffusion | 1 | 2017 | 84 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 2 | 2013 | 869 | 0.150 |
Why?
|
| Cross-Linking Reagents | 1 | 2018 | 112 | 0.150 |
Why?
|
| Luciferases | 1 | 2018 | 109 | 0.150 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 89 | 0.140 |
Why?
|
| Chelating Agents | 2 | 2018 | 47 | 0.140 |
Why?
|
| Optical Imaging | 1 | 2018 | 68 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 549 | 0.130 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2017 | 50 | 0.130 |
Why?
|
| Heart | 2 | 2017 | 274 | 0.130 |
Why?
|
| Photoacoustic Techniques | 1 | 2015 | 5 | 0.130 |
Why?
|
| Ferric Compounds | 1 | 2015 | 38 | 0.130 |
Why?
|
| Dextrans | 1 | 2015 | 44 | 0.130 |
Why?
|
| Survival Rate | 1 | 2018 | 787 | 0.130 |
Why?
|
| Child | 1 | 2025 | 4299 | 0.120 |
Why?
|
| Young Adult | 1 | 2025 | 4319 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 659 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2023 | 5975 | 0.120 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2014 | 98 | 0.120 |
Why?
|
| Manganese | 1 | 2014 | 24 | 0.120 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1129 | 0.110 |
Why?
|
| Adolescent | 1 | 2025 | 5916 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 170 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 138 | 0.110 |
Why?
|
| Gold | 1 | 2015 | 227 | 0.110 |
Why?
|
| 5-Hydroxytryptophan | 1 | 2012 | 3 | 0.100 |
Why?
|
| Pentetic Acid | 1 | 2012 | 32 | 0.100 |
Why?
|
| Blood Proteins | 1 | 2012 | 72 | 0.100 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 42 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 243 | 0.100 |
Why?
|
| Drug Stability | 1 | 2012 | 139 | 0.100 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 70 | 0.100 |
Why?
|
| Dependovirus | 3 | 2024 | 655 | 0.100 |
Why?
|
| Gadolinium | 1 | 2012 | 101 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 304 | 0.100 |
Why?
|
| Tissue Distribution | 1 | 2012 | 282 | 0.090 |
Why?
|
| Horseradish Peroxidase | 1 | 2011 | 16 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 427 | 0.090 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 158 | 0.090 |
Why?
|
| Time Factors | 1 | 2018 | 3567 | 0.090 |
Why?
|
| Kinetics | 1 | 2012 | 733 | 0.090 |
Why?
|
| Gadolinium DTPA | 1 | 2011 | 85 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 222 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 810 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2015 | 496 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2011 | 190 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 220 | 0.080 |
Why?
|
| Adult | 1 | 2025 | 15734 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 673 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2024 | 813 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 1547 | 0.070 |
Why?
|
| Abdomen | 2 | 2017 | 89 | 0.060 |
Why?
|
| Artifacts | 2 | 2017 | 126 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2024 | 7 | 0.060 |
Why?
|
| Miniaturization | 1 | 2024 | 8 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 56 | 0.060 |
Why?
|
| Microscopy | 1 | 2024 | 88 | 0.050 |
Why?
|
| X-Rays | 1 | 2022 | 44 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2022 | 21 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2023 | 81 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 35 | 0.050 |
Why?
|
| Simvastatin | 1 | 2022 | 28 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 304 | 0.050 |
Why?
|
| Exons | 1 | 2023 | 193 | 0.050 |
Why?
|
| Reflex | 1 | 2021 | 28 | 0.050 |
Why?
|
| Arginine | 1 | 2022 | 113 | 0.050 |
Why?
|
| Radiography, Interventional | 1 | 2022 | 67 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 94 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 169 | 0.050 |
Why?
|
| Astrocytes | 1 | 2021 | 115 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 338 | 0.050 |
Why?
|
| Mammography | 1 | 2022 | 272 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 262 | 0.040 |
Why?
|
| Sheep | 1 | 2020 | 166 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 459 | 0.040 |
Why?
|
| Cuprizone | 1 | 2018 | 3 | 0.040 |
Why?
|
| Remyelination | 1 | 2018 | 2 | 0.040 |
Why?
|
| PPAR delta | 1 | 2018 | 9 | 0.040 |
Why?
|
| Quetiapine Fumarate | 1 | 2018 | 13 | 0.040 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 14 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2023 | 1988 | 0.040 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2017 | 8 | 0.040 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2017 | 32 | 0.030 |
Why?
|
| Motion | 1 | 2017 | 55 | 0.030 |
Why?
|
| Neurons | 1 | 2021 | 858 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 172 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 210 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2015 | 67 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 312 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2014 | 72 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2015 | 180 | 0.030 |
Why?
|
| Models, Biological | 1 | 2017 | 1139 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1537 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 986 | 0.020 |
Why?
|